Please wait...
GulfBase Live Support
- Saudi Arabia's Maaden Successfully Raises $1 Billion Through 10-Year International Sukuk
- Bahrain All Share Index, Islamic Index close lower
- Venezuela Hopes to Boost Its Oil Production by 18 Percent in 2026
- US Fed set to keep rates steady despite Trump's pressure
- Global economy faces uncertainty in 2026; 53% WEF chief economists see weakness
- Oman Arab Bank launches new platform for SME growth
- 64% of consumers in Oman prefer non-cash payments: Visa
- Oman's bond and sukuk market records RO608mn gain in 2025
- QNB awarded for outstanding contribution to Franco-Qatari economic cooperation
- QSE index closes lower
- AVALONPHARMASaudi Stock Exchange (Kingdom of Saudi Arabia)
120.9
Last Update 04/12/2025 15:01 KSA
|
|
- :121.2
- :119.2
- ('000):20,000
- ( '000):2,418,000
- :0
-
23,339 - :0
- :
- 19.63%
- 4.63%
-
525 -
():
2,818,152.8 - ():3,372,518
- :0.84
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :29/06/1998
- :SAR 200,000,000
- :SAR 10.000
Activities
Middle East Pharmaceutical Industries Company is a prominent pharmaceutical company headquartered in Riyadh, Saudi Arabia. The company focuses on research, development, manufacturing, and marketing of generic medicines and pharmaceutical preparations. Their product portfolio includes treatments for various health conditions, such as: skin diseases, respiratory, central nervous, digestive, and musculoskeletal system disorders, urinary and reproductive system issues, diabetes, cardiovascular diseases, and anti-infective treatments, pain relief, antiseptics, and men's and women's health products. The company operates through three segments: Private, Public, and Export. Additionally, they offer contract manufacturing services and specialize in cosmetic, health products, and nutritional supplements. Formerly known as Middle East Chemical Products Factory Company, it changed its name to Middle East Pharmaceutical Industries Company in January 2006. The company also exports its products internationally, contributing to healthcare access beyond its home country.
-
Chairman:Ahmed S. A. Al-Tabbaa
-
Vice-chairman:Hisham M. M. Attar
-
CEO:Mohamed M. M. Al-Ghannam
-
General Manager:
-
Managing Director:
-
Board Members:
Faisal S. M. Al-Jaman
Mohammed M. Al-Ghannam
Omar M. S. Al-Jaroudi
-
Auditors:
KPMG Professional Consulting
CFO
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 05/11/2025 | 9-Month | 30/09/2025 | 52 | 49.79 |
| 10/08/2025 | 6-Month | 30/06/2025 | 44 | 41.81 |
| 12/05/2025 | 3-Month | 31/03/2025 | 19 | 107.07 |
| 23/03/2025 | 12-Month | 31/12/2024 | 80 | 21.3 |
| 07/11/2024 | 9-Month | 30/09/2024 | 35 | 0 |
- investor.relations@avalon.com.sa
- www.avalonpharmaceutical.com
- P.O. Box 3800 Riyadh 14331
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 22,927 | 251.2 | 2.19 | -10.75 | 36.49 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 7,833.31 | 2.68 | 3.47 | -21.04 | 25.62 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 3,744.33 | 70.25 | 0 | -21.68 | 19.91 | 2.62 | 0 | 0.81 | 13.85 | 22.49 |
| DALLAHHEALTH | 3,519.07 | 126.4 | -2.77 | -14.36 | 24.43 | 4.72 | 0 | 0.93 | 12.1 | 17.53 |
| JAMJOOMPHARMA | 2,816.91 | 151.7 | 0.46 | -1.56 | 24.26 | 0 | 0 | 0 | 0 | 0 |
| FAKEEHCARE | 2,290.11 | 37.02 | -0.06 | -43.1 | 26.71 | 0 | 0 | 0 | 0 | 0 |
| ALMOOSA | 1,965.87 | 167.2 | 0.42 | 0 | 39.9 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 1,870.23 | 1.35 | 2.27 | -37.14 | 1.47 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,697.26 | 144.5 | 1.76 | -13.1 | 20.37 | 7.46 | 0 | 0.85 | -0.59 | -0.89 |
| CHEMICAL | 1,575.24 | 7.14 | 1.85 | -27.73 | 21.2 | 0.28 | 0 | 0.81 | 3.83 | 8.71 |
| SMCHEALTHCARE | 1,245.89 | 19.04 | 1.81 | 0 | 30.94 | 0 | 0 | 0 | 0 | 0 |
| ALHAMMADI | 1,241.68 | 28.78 | -1.17 | -27.11 | 15.91 | 2.72 | 0 | 1.15 | 3.71 | 6.18 |
| SAUDIGERMANHEALTH | 941.9 | 38 | -1.05 | -45.38 | 8.86 | 3.07 | 0 | 0.79 | 11.92 | 18.76 |
| SPIMACO | 868.58 | 27.7 | 1.98 | -10.36 | 43.15 | 1.27 | 0 | 0.91 | 8.47 | 15.11 |
| AVALONPHARMA | 643.33 | 120.9 | 0.16 | 0.58 | 25.99 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 521.56 | 785 | 0 | -0.63 | 18.96 | 0 | 0 | 0 | 12.06 | 17.87 |
| JULPHAR | 380.49 | 1.37 | 13.22 | -6.92 | 31.35 | 0.64 | 5.27 | 0.2 | 4.09 | 0 |
| ATC.KW | 373.76 | 590 | -7.24 | 77.56 | -25.62 | 0 | 1.82 | -0.01 | 2.93 | 12.88 |
| GMPC | 372.88 | 1.96 | 0 | 4.81 | 0 | 1.08 | 3 | -0.08 | 75.81 | 111.42 |
| AYYAN | 362.87 | 13.72 | 1.4 | -2.8 | 4.19 | 1.26 | 0 | 0.81 | -2 | -2.64 |
| EQUIPMENTHOUSE | 259.84 | 33.88 | 4.24 | -37.74 | 32.72 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 254.51 | 1.95 | 2.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AME | 186.55 | 98.65 | -1.35 | 0 | 149.86 | 0 | 0 | 0 | 0 | 0 |
| RPM | 171.49 | 3.17 | 0.63 | -17.32 | 0 | 0 | 0 | 0 | 0 | 0 |
| NABAALSAHA | 165.38 | 55.9 | -5.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 151.59 | 14.2 | -0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 144.05 | 7.1 | 1.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TIBBIYAH | 130.59 | 24.66 | 0.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 94.56 | 5.05 | 1.4 | 0 | 8.92 | 0 | 0 | 0 | 0 | 0 |
| QOMEL | 92.08 | 49.9 | 1.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PROMEDEX | 88 | 97.5 | 3.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 56.12 | 107 | 1.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SMILECARE | 28.14 | 5.55 | 5.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 18.11 | 54 | -0.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 12.7 | 32.68 | 4.27 | 0 | 168.95 | 0 | 0 | 0 | 0 | 0 |
| JANA | 11.56 | 13.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| LANA | 3.96 | 2.79 | 1.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
Saudi Arabia